Biocon CEO Says Their Next Growth Trigger Could Arrive In Just 30 Days In The US Market by NDTV Profits | February 26, 2026 4:20 pm | Latest Posts, Market, Trending News Mittal said the opportunity remains meaningful despite the broader GLP-1 market shifting toward newer therapies such as Ozempic and Mounjaro.
